Increased CD163 expression has been linked to neuroinflammatory disease states such as multiple sclerosis[123], Alzheimer’s disease[124]) HIV-associated neurocognitive disorders[125] and schizophrenia[126]. Here, CD163 is linked to early-onset autosomal dominant Alzheimer disease.